Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Authors
Keywords
-
Journal
Future Microbiology
Volume 7, Issue 3, Pages 347-367
Publisher
Future Medicine Ltd
Online
2012-03-07
DOI
10.2217/fmb.12.4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
- (2011) Jianchun Bian et al. ARCHIVES OF VIROLOGY
- Efficacy of Newcastle Disease Virus Recombinant Expressing Avian Influenza Virus H6 Hemagglutinin Against Newcastle Disease and Low Pathogenic Avian Influenza in Chickens and Turkeys
- (2011) Diana Schröer et al. AVIAN DISEASES
- Cytoplasmic DNA innate immune pathways
- (2011) Glen N. Barber IMMUNOLOGICAL REVIEWS
- Roles of the Fusion and Hemagglutinin-Neuraminidase Proteins in Replication, Tropism, and Pathogenicity of Avian Paramyxoviruses
- (2011) S.-H. Kim et al. JOURNAL OF VIROLOGY
- Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells
- (2011) M. Mansour et al. JOURNAL OF VIROLOGY
- Newcastle Disease Virus-Vectored Rabies Vaccine Is Safe, Highly Immunogenic, and Provides Long-Lasting Protection in Dogs and Cats
- (2011) J. Ge et al. JOURNAL OF VIROLOGY
- Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs
- (2011) S. K. Khattar et al. JOURNAL OF VIROLOGY
- Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production
- (2011) Kathryn H. Richards et al. MICROBES AND INFECTION
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
- (2011) Alan Melcher et al. MOLECULAR THERAPY
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Subversion of the actin cytoskeleton during viral infection
- (2011) Matthew P. Taylor et al. NATURE REVIEWS MICROBIOLOGY
- Cytolytic Effects and Apoptosis Induction of Newcastle Disease Virus Strain AF2240 on Anaplastic Astrocytoma Brain Tumor Cell Line
- (2011) Rola Ali et al. NEUROCHEMICAL RESEARCH
- A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen
- (2011) Sa Xiao et al. VACCINE
- The matrix (M) protein of newcastle disease virus binds to human bax through its BH3 domain
- (2011) Aidin Molouki et al. Virology Journal
- Protection Induced by Infectious Laryngotracheitis Virus Vaccines Alone and Combined with Newcastle Disease Virus and/or Infectious Bronchitis Virus Vaccines
- (2010) Ariel Vagnozzi et al. AVIAN DISEASES
- Generation and Evaluation of a Newcastle Disease Virus–Based H9 Avian Influenza Live Vaccine
- (2010) Jinying Ge et al. AVIAN DISEASES
- The anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting
- (2010) Hong Sui et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements
- (2010) Khalid S. A. Khabar CELLULAR AND MOLECULAR LIFE SCIENCES
- Sensing and Signaling in Antiviral Innate Immunity
- (2010) Luke A.J. O'Neill et al. CURRENT BIOLOGY
- Recognition of viruses by cytoplasmic sensors
- (2010) Courtney Wilkins et al. CURRENT OPINION IN IMMUNOLOGY
- Viral tricks to grid-lock the type I interferon system
- (2010) Gijs A Versteeg et al. CURRENT OPINION IN MICROBIOLOGY
- Directing systemic oncolytic viral delivery to tumors via carrier cells☆
- (2010) Hiroshi Nakashima et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Use of attenuated paramyxoviruses for cancer therapy
- (2010) Patrycja J Lech et al. Expert Review of Vaccines
- Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
- (2010) Pingdong Li et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
- (2010) Kyo Young Song et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Type I Interferon-Sensitive Recombinant Newcastle Disease Virus for Oncolytic Virotherapy
- (2010) S. Elankumaran et al. JOURNAL OF VIROLOGY
- Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
- (2010) J. Maamary et al. JOURNAL OF VIROLOGY
- The Viral Replication Complex Is Associated with the Virulence of Newcastle Disease Virus
- (2010) J. C. F. M. Dortmans et al. JOURNAL OF VIROLOGY
- Induction of Type I Interferon Secretion through Recombinant Newcastle Disease Virus Expressing Measles Virus Hemagglutinin Stimulates Antibody Secretion in the Presence of Maternal Antibodies
- (2010) D. Kim et al. JOURNAL OF VIROLOGY
- Genetically Engineered Oncolytic Newcastle Disease Virus Effectively Induces Sustained Remission of Malignant Pleural Mesothelioma
- (2010) G. R. Silberhumer et al. MOLECULAR CANCER THERAPEUTICS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus
- (2010) J Puhlmann et al. ONCOGENE
- Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
- (2010) Joshua M. DiNapoli et al. VACCINE
- Antitumor vaccination by Newcastle Disease Virus Hemagglutinin–Neuraminidase plasmid DNA application: Changes in tumor microenvironment and activation of innate anti-tumor immunity
- (2010) Jing Ni et al. VACCINE
- Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis
- (2009) Dominik E. Dorer et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
- (2009) K. S. Peggs et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model
- (2009) E. K. Mader et al. CLINICAL CANCER RESEARCH
- Genetically engineered Newcastle disease virus for malignant melanoma therapy
- (2009) D Zamarin et al. GENE THERAPY
- Newcastle Disease Virus Infection Promotes Bax Redistribution to Mitochondria and Cell Death in HeLa Cells
- (2009) Aidin Molouki et al. INTERVIROLOGY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin
- (2009) I. Lazar et al. JOURNAL OF VIROLOGY
- Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
- (2009) Dmitriy Zamarin et al. MOLECULAR THERAPY
- Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
- (2009) Jennifer Altomonte et al. MOLECULAR THERAPY
- Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis
- (2009) P.V. Ravindra et al. VIRUS RESEARCH
- Time course of Newcastle disease virus-induced apoptotic pathways
- (2009) P.V. Ravindra et al. VIRUS RESEARCH
- HN protein of Newcastle disease virus causes apoptosis in chicken embryo fibroblast cells
- (2008) P. V. Ravindra et al. ARCHIVES OF VIROLOGY
- Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
- (2008) B Yaacov et al. CANCER GENE THERAPY
- Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
- (2008) T. Schulze et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes
- (2008) F Pühler et al. GENE THERAPY
- The Large Polymerase Protein Is Associated with the Virulence of Newcastle Disease Virus
- (2008) S. N. Rout et al. JOURNAL OF VIROLOGY
- Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
- (2008) Adam Vigil et al. MOLECULAR THERAPY
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
- Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma
- (2008) M. M. Zulkifli et al. NEUROLOGICAL RESEARCH
- Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
- (2008) Heng Zhao et al. VIRUS RESEARCH
- Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de-novo protein synthesis and caspase activation
- (2008) P.V. Ravindra et al. VIRUS RESEARCH
- Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
- (2007) R. E. Randall et al. JOURNAL OF GENERAL VIROLOGY
- A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus
- (2007) John Steel et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started